Article
Chemistry, Medicinal
Zheng-Sheng Lai, Teng-Kuang Yeh, Yu-Chi Chou, Tsu Hsu, Cheng-Tai Lu, Fang-Chun Kung, Ming-Yen Hsieh, Chun-Hung Lin, Chiung-Tong Chen, Che-Kun James Shen, Weir-Torn Jiaang
Summary: A more potent inducer, compound 13a, was discovered in this study, which can efficiently induce gamma-globin gene expression at non-cytotoxic concentrations and ameliorate anemia and related symptoms in SCD mice through oral administration.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
(2021)
Article
Multidisciplinary Sciences
Neha Kargutkar, Madhavi Sawant-Mulay, Priya Hariharan, S. Chandrakala, Anita Nadkarni
Summary: Hydroxyurea (HU) is beneficial in sickle cell anaemia (SCA) patients by increasing foetal haemoglobin (HbF), but the response varies. The role of miRNA in HbF regulation has been minimally investigated. In this study, miRNA expression and HbF induction were evaluated in relation to HU therapy. After 3 months of HU therapy, HbF levels increased significantly. Several miRNAs were up-regulated or down-regulated after HU therapy, and certain miRNAs were strongly associated with HbF induction. The study suggests that miR-210, miR16-1, miR-29a, and miR-96 play a role in regulating the gamma-globin gene and HbF induction.
SCIENTIFIC REPORTS
(2023)
Letter
Medicine, General & Internal
Molly M. Jeffery, Maria Stevens, Gail D'Onofrio, Edward R. Melnick
Summary: From 2016 to 2021, there was a 282% increase in drug-overdose deaths associated with fentanyl outside of healthcare settings, with the death rate rising from 46.6 per million to 178.0 per million.
NEW ENGLAND JOURNAL OF MEDICINE
(2023)
Review
Chemistry, Medicinal
Annamaria Aprile, Silvia Sighinolfi, Laura Raggi, Giuliana Ferrari
Summary: Research in the last decade has shown multiple alterations of the BM niche in beta-thalassemia and sickle cell disease, emphasizing the importance of understanding the interaction between HSC biology and the BM microenvironment in improving clinical outcomes of transplantation.
Review
Biochemistry & Molecular Biology
Rayan Bou-Fakhredin, Lucia De Franceschi, Irene Motta, Assaad A. Eid, Ali T. Taher, Maria Domenica Cappellini
Summary: Beta-thalassemia and sickle cell disease lead to variations in hemoglobin, which affect the oxidative environment. Oxidative stress plays a significant role in these diseases, causing cellular damage. This review summarizes the mechanisms and therapeutic strategies of oxidative stress in these diseases, and discusses the role of targeted therapy.
Article
Hematology
Alice Tang, Ana Nicolle Strat, Mahmudur Rahman, Helen Zhang, Weili Bao, Yunfeng Liu, David Shi, Xiuli An, Deepa Manwani, Patricia Shi, Karina Yazdanbakhsh, Avital Mendelson
Summary: Studies have found that murine SCD MSCs exhibit altered gene signatures, reduced stem cell properties, and increased oxidative stress, leading to decreased HSC maintenance ability. The activation of Toll-like receptor-4 through p65 in MSCs further exacerbates MSC dysfunction in SCD.
Review
Medicine, General & Internal
Raffaella Colombatti, Inga Hegemann, Morten Medici, Camilla Birkegard
Summary: Sickle cell disease is a genetic disorder with a high prevalence in sub-Saharan Africa, the Mediterranean basin, the Middle East, and India. A systematic literature review identified 115 publications on SCD epidemiology, showing highest prevalence in Africa, the Middle East, and India, and lowest in Europe. The study revealed a lack of systematic knowledge and the need for uniform data collection on SCD prevalence and mortality.
JOURNAL OF CLINICAL MEDICINE
(2023)
Article
Pharmacology & Pharmacy
Michael Voronkov, Georgiy Nikonov, Janna Ataiants, Levon Isakulyan, Cristina Stefanut, Mihai Cernea, John Abernethy
Summary: Developing an effective antidote for fentanyl-induced overdose is an important medical need. In this study, a bioreversible derivative of naloxone, NX-90, was synthesized and evaluated for its ability to reverse fentanyl-induced overdose in rats. The results showed that NX-90 restored all monitored reflexes, heart rate, and respiratory rate faster than naloxone on equimolar bases when given intranasally. In addition to its improved pharmacodynamics profile, NX-90 had lower levels of circulating naloxone and demonstrated a robust release of the parent naloxone in the brain. Based on these findings, NX-90 was identified as a promising intranasal fentanyl antidote for further preclinical development.
INTERNATIONAL JOURNAL OF PHARMACEUTICS
(2022)
Article
Biotechnology & Applied Microbiology
Sophie Ramadier, Anne Chalumeau, Tristan Felix, Nadia Othman, Sherazade Aknoun, Antonio Casini, Giulia Maule, Cecile Masson, Anne De Cian, Giacomo Frati, Megane Brusson, Jean-Paul Concordet, Marina Cavazzana, Anna Cereseto, Wassim El Nemer, Mario Amendola, Benoit Wattellier, Vasco Meneghini, Annarita Miccio
Summary: In this study, a novel therapeutic approach combining LV-based gene addition and CRISPR-Cas9 strategies was developed to treat Sickle Cell Disease. This versatile platform reduced the expression of sickle beta-globin and increased the expression of anti-sickling globins, resulting in improved treatment efficacy.
Article
Medicine, General & Internal
Malavika Shankar, Nicole Gousy, Tutul Chowdhury
Summary: Sickle cell disease variants can present as life-threatening complications or milder symptoms. Early investigation of these symptoms may reduce the risk of severe complications.
CUREUS JOURNAL OF MEDICAL SCIENCE
(2022)
Review
Chemistry, Medicinal
Rayan Bou-Fakhredin, Lucia De Franceschi, Irene Motta, Maria Domenica Cappellini, Ali T. Taher
Summary: Better understanding of gamma-globin regulation has led to advancements in pharmacologic agents for HbF induction and identification of novel HbF-inducing strategies.
Article
Multidisciplinary Sciences
Lianping K. Ti, Cameron Grant, Samuel Tobias, Dennis Hore, Richard Laing, Brandon D. L. Marshall
Summary: In this study, a neural network model was developed to accurately identify fentanyl and related analogues in drug samples using FTIR data. The model outperformed traditional analysis by technicians and has the potential to improve decision making in drug checking services.
Review
Hematology
Sherif M. Badawy, Usman Beg, Robert Liem, Sonali Chaudhury, Alexis A. Thompson
Summary: There is increasing interest in curative therapies for patients with sickle cell disease (SCD) and thalassemia, including hematopoietic stem cell transplant (HSCT) and gene therapy. Research shows that HSCT has a positive impact on HRQOL, with potential for improvement in HRQOL outcomes following gene therapy in patients with SCD and thalassemia.
Article
Biochemical Research Methods
Christina Lisk, Francesca Cendali, Saini Setua, Kiruphararan Thangaraju, David I. I. Pak, Delaney Swindle, Monika Dzieciatkowska, Fabia Gamboni, Kathryn Hassell, Rachelle Nuss, Gemlyn George, Pavel Davizon-Castillo, Paul W. W. Buehler, Angelo D'Alessandro, David C. C. Irwin
Summary: Sickle cell disease and beta-thalassemia are hemoglobinopathies caused by dysfunctional or underproduced beta-globin chains. The polarization and reprogramming of macrophages in tissue compartments may be relevant to disease progression. Mouse models of beta-globinopathy provide insights into the mechanisms and translation to human disease. A multi-omics approach was used to study macrophage metabolism and protein changes in two murine models, revealing distinct phenotypes and disease-specific reprogramming in different tissue compartments.
JOURNAL OF PROTEOME RESEARCH
(2023)
Review
Urology & Nephrology
Kenneth Ataga, Santosh L. Saraf, Vimal K. Derebail
Summary: Sickle cell syndromes are associated with kidney abnormalities and nephropathy. The pathophysiology of SCD-related nephropathy is multifactorial, including oxidative stress, hyperfiltration, and glomerular hypertension. Patients with SCD experience faster decline in kidney function and often present with albuminuria. Multiple genetic modifiers are also implicated in the development and progression of SCD-related nephropathy. Chronic kidney disease and rapid decline in estimated glomerular filtration rate are associated with increased mortality in SCD patients.
NATURE REVIEWS NEPHROLOGY
(2022)